<DOC>
	<DOCNO>NCT03053518</DOCNO>
	<brief_summary>This initial validation study Personal Nutrition Project ( PNP ) algorithm North American population recently diagnose Type 2 Diabetes ( T2D ) . This 2-stage , single-group feeding study 20 individual , include 10 participant manage lifestyle alone , 10 manage lifestyle plus metformin .</brief_summary>
	<brief_title>Validation Machine Learning Based Personalized Nutrition Algorithm Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes</brief_title>
	<detailed_description>The PNP algorithm , use machine learn algorithm predict postprandial glycemic , may efficacious generate tailored dietary advice moderate participant 's glycemic response food .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age &gt; 21 year &lt; 70 year Diagnosed T2DM within 2 year HbA1c &lt; 7 % Diabetes management metformin lifestyle intervention Fasting Cpeptide ≥ 0.5 mg/mL ( 0.17 nmol/L ) ( exclude hyperglycemic exposure drive βcell failure rather dietary behavior , well require escalation medication regime ) Ownership smart phone willing use monitor multiple factor influence glycemic response glycemia ( e.g. , sleep , physical activity , diet , stress , medication , hunger ) unable unwilling provide inform consent ; unable participate meaningfully intervention involves selfmonitoring use software available English ( e.g. , due uncorrected sight impairment , illiterate , nonEnglishspeaking , dementia ) ; pregnant , currently try become pregnant , become pregnant study institutionalize ( e.g. , nursing home personal care facility , incarcerate limited control selfmanagement ) plan bariatric surgery study history heart disease , kidney disease , retinopathy ( ruleout longstanding , undiagnosed T2D ) active infection require antibiotic last 3 month develop active infection require antibiotic study ; use acetaminophen unwilling unable discontinue use study ( acetaminophen affect CGM accuracy ) 39 immunosuppressive drug within three month prior participation Chronically active inflammatory neoplastic disease three year prior enrollment . Patients know food allergy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Personal Nutrition Project</keyword>
</DOC>